-
ERDF at the Cross Roads?
The 2007-13 English regional ERDF programmes are rapidly moving into a critical make or break phase. They have just two more years to invest what is still a significant amount of uncommitted money. The programmes have experienced very tough operating conditions having navigated through an intense recession which has fundamentally changed economic opportunities. Business growth and job creation o...
-
RGF Round 1 Successes: What can we learn?
The Government announced this month that £450m out of the total £1.4 billion Regional Growth Fund would be allocated to around 50 successful Round 1 bids, subject to due diligence checks. The published information from BIS on successful bids has so far been somewhat limited; however through announcements by successful bidders and local press coverage, we have been able to start to piece togethe...
-
New Enterprise Zones – worth all the fuss?
The dust has settled a little after the 2011 Budget and what’s happening about Enterprise Zones has become a little clearer. I’ve had a good look at the EZ Prospectus published by DCLG and read between the lines (see http://www.communities.gov.uk/documents/localgovernment/pdf/1872724.pdf). What’s the scale of EZs this time round? The Government has announced that there will 21 EZs in England...
-
Pfizer Closure Will Test the UK’s Growth Strateg...
I suspect we all were surprised by the news that the world’s biggest drug maker Pfizer intends to close its R&D facility in Sandwich, Kent. This is the drug giant’s largest research facility in Europe, is home to world-class centres of excellence in a number of therapeutic areas (certain such as allergy, respiration and … ahem…. even erectile dysfunction) and has been the recipient of substantia...
Page 1 of 1 pages
